🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a prospective, single-arm trial. The main purpose of the study is t...
Status
Recruiting
Location
Zhejiang Provincial People's Hospital
Start Date
2024-11-15
Trial ID
NCT06722911
Treatments Being Tested
Radiation Plus Concurrent Nimotuzumab in Elderly Patients With Locoregional...
Status
Completed
Location
Xiaozhong Chen
Start Date
2017-03-13
Trial ID
NCT03025958
Treatments Being Tested
The purpose of this study is to observe and evaluate the efficacy and safet...
Status
Unknown
Location
The First Affiliated Hospital of Zhengzhou University
Start Date
2021-09
Trial ID
NCT03766178
Treatments Being Tested
Determination of efficiency of nimotuzumab in children with high grade glio...
Status
Completed
Location
University Bonn, Children's Medical Hospital
Start Date
2004-06
Trial ID
NCT00561873
The prognosis of patients with inoperable locally advanced or residual/rela...
Status
Unknown
Location
Radiotherapy Department of Cancer Hospital, Chinese Academy of Medical Sciences
Start Date
2010-05
Trial ID
NCT01180166
Treatments Being Tested
To evaluate the efficacy and safety of nimotuzumab in the treatment of EGFR...
Status
Unknown
Location
Tianjin Medical University Second Hospital
Start Date
2022-12-01
Trial ID
NCT06022276
Treatments Being Tested
Nimotuzumab, as one new agent used in advanced esophageal carcinoma, has be...
Status
Unknown
Location
Xiaodong Zhang
Start Date
2011-03
Trial ID
NCT01336049
Treatments Being Tested
This is a prospective, Bayesian adaptive, phase II clinical trial designed ...
Status
Recruiting
Location
Cancer Center of Guangzhou Medical University
Start Date
2025-06-24
Trial ID
NCT07070479
The primary objective of this study is to assess the efficacy of nimotuzuma...
Status
Completed
Location
Hospital Evangélico do Cachoeiro do Itapemirim
Start Date
2009-01
Trial ID
NCT01249352
Treatments Being Tested
Combining nimotuzumab to gefitinib may not only potentiate cellular cytotox...
Status
Completed
Location
Severance hospital, Yonsei Cancer Center
Start Date
2011-12
Trial ID
NCT01498562
Treatments Being Tested